We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mesenchymal Stem Cells; Donor and Role in Management and Reconstruction of Nonunion Fracture

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01626625
Recruitment Status : Unknown
Verified June 2012 by Ismail Hadisoebroto Dilogo, Indonesia University.
Recruitment status was:  Recruiting
First Posted : June 25, 2012
Last Update Posted : June 25, 2012
Sponsor:
Information provided by (Responsible Party):
Ismail Hadisoebroto Dilogo, Indonesia University

June 12, 2012
June 25, 2012
June 25, 2012
April 2010
April 2015   (Final data collection date for primary outcome measure)
healing of fracture [ Time Frame: 1 year ]
radiological union
Same as current
No Changes Posted
VAS [ Time Frame: 1 year ]
visual analogue scale
Same as current
Not Provided
Not Provided
 
Mesenchymal Stem Cells; Donor and Role in Management and Reconstruction of Nonunion Fracture
Not Provided
The investigators hypothesized that mesenchymal stem cells can be isolated from fracture site, iliac crest, and tibial crest, and can be expanded to be used in the management of nonunion fracture.
Not Provided
Interventional
Phase 1
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Healing of Fracture
  • Drug: stem cells + hydroxy apatite
    patient will be transplanted with stem cells and hydroxyapatite
  • Other: autograft taken from iliac crest
    patient will be transplanted with autograft
  • Experimental: stem cells
    stem cells + hydroxy apatite
    Intervention: Drug: stem cells + hydroxy apatite
  • Active Comparator: autograft
    Intervention: Other: autograft taken from iliac crest
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
10
January 2016
April 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • athropic nonunion fracture of the long bone

Exclusion Criteria:

  • immunocompromise,
  • active infection,
  • pathological fracture,
  • ongoing hormonal therapy
Sexes Eligible for Study: All
18 Years to 55 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
Indonesia
 
 
NCT01626625
NONUNISTEM1
Yes
Not Provided
Not Provided
Ismail Hadisoebroto Dilogo, Indonesia University
Indonesia University
Not Provided
Not Provided
Indonesia University
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP